RIGL Stock News 2.94 05/13/2014 17:28:42 Rigel Pharmaceuticals

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Rigel Pharmaceuticals (RIGL) 2.94 $RIGL

Biotech Equities Technical Momentum -- Research on Ironwood Pharma, Neurocrine Biosciences, Rigel Pharma, and Seattle Genetics
PR Newswire - Thu May 08, 8:10AM CDT
The trading session on Wednesday, May 07, 2014 ended on a mixed note as the Dow Jones Industrial Average finished at 16,518.54, up 0.72% and the NASDAQ Composite closed at 4,067.67, down 0.32%. The S&P 500 finished the day 0.56% higher at 1,878.21. During the trading session eight out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day 0.23% higher at 668.01, and the index has advanced 2.50% in the previous three months. Investor-Edge has initiated coverage on the following equities: Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD), Neurocrine Biosciences Inc. (NASDAQ: NBIX), Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) and Seattle Genetics Inc. (NASDAQ: SGEN). Free technical research on IRWD, NBIX, RIGL and SGEN can be downloaded upon signing up at:

Stock to Watch: Rigel Pharmaceuticals Down 6.6% (RIGL)
Comtex SmarTrend(R) - Wed May 07, 12:45PM CDT
Rigel Pharmaceuticals (NASDAQ:RIGL) is one of today's worst performing low-priced stocks, down 6.6% to $2.82 on 1.1x average daily volume. Rigel Pharmaceuticals has traded 833,000 shares thus far today, vs. average volume of 771,000 shares per day. The stock has underperformed the Dow (-6.6% to the Dow's 0.6%) and underperformed the S&P 500 (-6.6% to the S&P's 0.3%) during today's trading.

Rigel Announces First Quarter 2014 Financial Results
PR Newswire - Wed May 07, 6:30AM CDT
Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the first quarter ended March 31, 2014.

Rigel Announces Webcast of Investor Day on May 6, 2014
PR Newswire - Wed Apr 30, 6:30AM CDT
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will host an Investor Day on Tuesday, May 6, 2014 from 9:30 a.m. to 12:00 p.m. E.T. in New York City. Rigel management will provide an overview of the company's product portfolio and discuss future strategy.

Is Rigel Pharmaceuticals (RIGL) Stock a Solid Choice Right Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 7:46AM CDT
Rigel Pharmaceuticals has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month

Health Care Sector Stocks under Review -- Research on Sanofi, Impax Laboratories, Keryx Biopharma, and Rigel Pharma
PR Newswire - Tue Apr 08, 12:59PM CDT
The trading session on Monday, April 07, 2014 ended on a lower note as the S&P 500 finished the session 1.08% lower at 1,845.04 and the NASDAQ Composite closed at 4,079.75, down 1.16%. The Dow Jones Industrial Average finished at 16,245.87, down 1.02%. During the session, nine out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index finished the day at 664.68, down 1.06%, and the same has declined 2.85% in the previous three trading sessions. Investor-Edge has initiated coverage on the following equities: Sanofi (NYSE: SNY), Impax Laboratories Inc. (NASDAQ: IPXL), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) and Rigel Pharmaceuticals Inc. (NASDAQ: RIGL). Free technical research on SNY, IPXL, KERX and RIGL can be downloaded upon signing up at:

Health Care Equities Analysis -- Research on Keryx Biopharma, Rigel Pharma, Sanofi and Impax Laboratories
PR Newswire - Wed Mar 19, 7:41AM CDT
On Tuesday, March 18, 2014, the NASDAQ Composite ended at 4,333.31, up 1.25%, the S&P 500 advanced 0.72% to 1,872.25, and the Dow Jones Industrial Average closed at 16,336.19, up 0.55%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index finished the day at 688.96, up 1.17%, and the same has advanced 1.47% in the last one month. Investor-Edge has initiated coverage on the following equities: Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Rigel Pharmaceuticals Inc. (NASDAQ: RIGL), Sanofi (NYSE: SNY) and Impax Laboratories Inc. (NASDAQ: IPXL). Free technical research on KERX, RIGL, SNY and IPXL can be downloaded upon signing up at:

Why VAALCO Energy, Rigel Pharmaceuticals, and Companhia Siderurgica Nacional Are Today's 3 Best Stoc
Sean Williams, The Motley Fool - Motley Fool - Fri Mar 14, 4:15PM CDT
The negativity continued on Wall Street and with the broad-based S&P 500 today following two economic reports that came in weaker than expected. First, the Producers Price Index for February  fell 0.1% against expectations for a rise of...

Regulatory Approvals, Pricing of Public Offering, Stock Price Movements, and Financial Reports - Analyst Notes on Arrowhead, ANI, OraSure, Rigel, and Foundation Medicine
PR Newswire - Mon Mar 10, 11:30AM CDT
Today, Analysts Review released its analysts' notes regarding Arrowhead Research Corp. (NASDAQ: ARWR), ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), OraSure Technologies, Inc. (NASDAQ: OSUR), Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), and Foundation Medicine, Inc. (NASDAQ: FMI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

This Week in Biotech: Put It in Print
Sean Williams, The Motley Fool - Motley Fool - Sat Mar 08, 1:05PM CST
With the  SPDR S&P Biotech Index  up  62% over the trailing-12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and...

Rigel (RIGL) Worth Watching: Stock Rises 10.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 8:46AM CST
Rigel was a big mover last session, as the company saw its shares rise over 10% on the day.

Why Rigel Pharmaceuticals, Inc. Shares Popped
Alex Planes, The Motley Fool - Motley Fool - Thu Mar 06, 12:50PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Rigel Pharmaceuticals   are trading about...

Rigel Rises on Narrower Q4 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 8:40AM CST
Rigel Pharma's 4Q13 loss of 19 cents per share was narrower than the Zacks Consensus Estimate of a loss of 24 cents and the year-ago loss of 30 cents per share

Top Stories in Biotech This Morning: Pluristem Therapeutics, Inc, Rigel Pharmaceuticals, Inc. and Sa
George Budwell, The Motley Fool - Motley Fool - Thu Mar 06, 7:49AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. Let's take a look at the top stories in biotech and health...

Rigel Announces Publication of R118 AMPK Activator Research
PR Newswire - Thu Mar 06, 6:30AM CST
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that the American Journal of Physiology has published recent research results with its orally-bioavailable AMPK activator, R118. The publication, entitled "Exercise performance and peripheral vascular insufficiency improve with AMPK activation...", provides strong preclinical evidence that R118 may be useful in treating peripheral artery disease (PAD), a chronic and progressive vascular disease effecting nearly 5% of the population over the age of 50, and related metabolic disorders. This publication extends work from a previous Rigel publication on the mechanism and impact of AMPK activation. The Company also announced that it has commenced Phase 1 clinical studies with R118 as a potential treatment for Intermittent Claudication (IC), a painful and debilitating outcome of PAD.

Stock to Watch: Rigel Pharmaceuticals Up 6.8% (RIGL)
Comtex SmarTrend(R) - Wed Mar 05, 11:40AM CST
Rigel Pharmaceuticals (NASDAQ:RIGL) is one of today's best performing low-priced stocks, up 6.8% to $3.95 on 2.5x average daily volume. Rigel Pharmaceuticals has traded 1.7 million shares thus far today, vs. average volume of 703,000 shares per day. The stock has outperformed the Dow (6.8% to the Dow's -0.2%) and outperformed the S&P 500 (6.8% to the S&P's -0.0%) during today's trading.

Rigel Pharmaceuticals posts lower net loss of USD89.0m in 2013
M2 - Wed Mar 05, 6:21AM CST
Drug company Rigel Pharmaceuticals (NasdaqGS:RIGL) on Tuesday reported a net loss of USD89.0m (USD1.02 per basic and diluted share) for the year ended 31 December 2013.

Rigel Announces Fourth Quarter and Year End 2013 Financial Results
PR Newswire - Tue Mar 04, 6:30AM CST
Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the fourth quarter and year ended December 31, 2013.

Rigel Announces Participation at Two Investor Conferences
PR Newswire - Thu Feb 27, 6:30AM CST
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that company management will present at two upcoming investor conferences. Details of the events are as follows:

Rigel Pharmaceuticals Up 6.1%, Shares Break Through Resistance (RIGL)
Comtex SmarTrend(R) - Mon Feb 24, 10:12AM CST
Rigel Pharmaceuticals (NASDAQ:RIGL) is one of today's best performing low-priced stocks, up 6.1% to $3.66 on 1.8x average daily volume. Thus far today, Rigel Pharmaceuticals has traded 1.1 million shares, vs. average volume of 615,000 shares per day. The stock has outperformed the Dow (6.1% to the Dow's 0.9%) and outperformed the S&P 500 (6.1% to the S&P's 0.9%) during today's trading.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PEGATRON Unveils AI and HPC Advances at SC26

Updated Category News Views 128

Revamping AI with High-Density Computing You know, back in the day, AI was just about training models and running basic inference. But now, it's all about these crazy agentic AI tasks—autonomous agents doing things I couldn't have imagined. PEGATRON's Evolution in Infrastructure PEGATRON's latest move at SC26 is a real leap forward in this ongoing AI saga. They're...

Continue Reading
Memorial Manor's Five-Star Signal in Long-Term Care

Updated Category News Views 81

Care quality is the only score that matters here A nursing home recognition is not the sort of news anybody should read like a trophy-case press release and then forget by lunch. Families make decisions around long-term care when they are tired, worried, and often dealing with a parent or spouse whose needs have changed fast. In that setting, a facility putting up both a...

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 317

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
Teamsters Ratify Contract, Averting Waste Strike

Updated Category News Views 141

Big Win for Teamsters Local 350 You ever seen a strike averted by sheer willpower and unity? That’s what's happened here with the workers at South San Francisco Scavenger Company. These folks—drivers, mechanics, sorters, and utility workers—all banded together under the Teamsters Local 350 and showed management what's what by securing a contract they deserve. We're...

Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 47

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading
Thoughts Unleashed Arrives With a Personal American Voice

Updated Category News Views 81

A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...

Continue Reading
Toledo Crosswalk Death Lawsuit Raises Hard Questions

Updated Category News Views 144

A painted crosswalk is supposed to mean something, and that is the grim center of the lawsuit filed over Judy Tanner’s death in Toledo. Tanner, 20, was walking home from work on September 10, 2026, when she was struck and killed while crossing the street. Her estate is now suing, alleging that the 31-year-old driver failed to yield as Tanner legally used the crosswalk....

Continue Reading
Sharon Stuart's Quest for Her Hidden Origins

Updated Category News Views 123

Delving Into Identity: A Personal Odyssey In a world where everyone seems to be searching for something, Sharon Stuart's quest is etched with the raw need to uncover her real origins. Abandoned as a newborn in the gritty streets of Oakland, she grew up grappling with looming questions about what made her who she is. Her journey is captured in her memoir, "Existing Without...

Continue Reading
Fuel Cell Market Faces Uneven Growth Amid Revenue Shifts

Updated Category News Views 144

Fuel Cell Sector Eyes Mixed Results and Big Projections The fuel cell market, oh what a beast it's becoming—a story filled with ups and downs, and more forecasts than a weather station. As we stand, this sector is poised to balloon to an $18.16 billion market by 2030. That's a growth rate of 26.3% annually, folks. These projections are driving excitement, but the...

Continue Reading
Inhabit Puts AI Across Its Property Management Stack

Updated Category News Views 37

Property managers do not need another shiny chatbot; they need fewer dropped leads, fewer invoice-entry mistakes and less staff time burned chasing routine answers. That is the sensible hook in Inhabit's OPTECH 2026 announcement. The company is spreading AI, integrations and scalability work across ResMan, Anyone Home, ePremium, Nationwide Compliant and several adjacent...

Continue Reading

Top 5 Most Recently Viewed Articles

ADT Inc. Pricing for Secondary Offering and Share Repurchase

Updated Category News Views 210

ADT Inc. Moves Forward with Secondary Public Offering ADT Inc. (NYSE: ADT) has made waves in the financial world by announcing the pricing of a secondary public offering. This significant event involves 56 million shares of common stock that are being sold by certain entities associated with Apollo Global Management, Inc. The process is designed to provide liquidity and...

Continue Reading
Exciting Updates from illumin Holdings Regarding Q2 2025 Results

Updated Category News Views 176

Upcoming Financial Results Announcement Toronto and New York - illumin Holdings Inc. (TSX: ILLM, OTCQB: ILLMF), renowned in the digital advertising technology sector, is gearing up to present its second quarter 2025 financial outcomes. These results are set to be unveiled before market operations commence on an announced date. Join Us for the Live Webcast All interested...

Continue Reading
Exploring Growth in the Mining Remanufacturing Sector

Updated Category News Views 168

Understanding the Mining Remanufacturing Components Market This comprehensive analysis provides insights into the growth of the mining remanufacturing components market. It highlights the increasing demand for sustainable practices, innovations, and market dynamics. Market Size and Growth Rate The mining remanufacturing components market was valued at around US$ 4.20...

Continue Reading
Novo Nordisk's Wegovy Trial Success: Weight Loss Breakthrough

Updated Category News Views 787

Groundbreaking Results from Novo Nordisk's Wegovy® Trial The latest findings from Novo Nordisk indicate a significant breakthrough in weight management through the higher dose of Wegovy, which has delivered an impressive average weight loss of 21% for individuals suffering from obesity. The trial results, presented at a prominent diabetes conference, revealed that...

Continue Reading
Builders FirstSource Announces Leadership Transition Plans

Updated Category News Views 230

Leadership Changes at Builders FirstSource Builders FirstSource, Inc. (NYSE: BLDR) is undergoing a major leadership shift as part of a planned transition. The company has announced that Peter Jackson, who currently serves as the Chief Financial Officer, will step into the role of President and Chief Executive Officer. This change marks an important milestone in the...

Continue Reading